Experiencing persistent joint pain, fatigue or unexplained rashes? These could be signs of an autoimmune condition.

Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today provided an update on recent and anticipated ...

Research and development expenses were $14.9 million for the three months ended June 30, 2025, compared to $12.7 million for the three months ended June 30, 2024. The increase in expenses was ...

ZUG, Switzerland and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, that can generally be identified by words such as ...

“People living with SLE face a heavy burden and few treatment options,” added Dr. Jörn Drappa, Alumis’ Chief Medical Officer ... release contains forward-looking statements within the meaning of ...

Vitamin D is sometimes nicknamed the “sunshine vitamin” because your skin makes it when you’re out in the sun. You can also ...

What is medical billing and coding? Find out what medical billers and coders do and how to enter one of these professions.

Can a Medical Device Restore Your Balance? Nearly two million people worldwide have lost the simple ability to feel steady. Now researchers have developed an experimental medical implant that ...

Here's what to know about July's full buck moon, the moon phases and when is the Mercury Retrograde. When is the next full moon in July 2025? The buck moon reached peak illumination at 4:37 p.m ...

In his new song, "Walking Away," Justin Bieber opens up about his marital struggles with Hailey.

Appointments of new CEO, CFO, and seasoned business development leaders with proven track records of executing strategic transactions will position the Company to drive shareholder value and advance ...